SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Emergent BioSolutions Initiates Phase 1b Study of TRU-016 in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia